Updated Feb. 20, 2012 at 3:58 p.m.

Premium Lock RTP startup focused on diabetes raises $2.5M

Published: 2012-02-20 12:36:00
Updated: 2012-02-20 15:58:59

Diabetes research Diabetes research

Lumena's investors are venture capital firms Pappas Ventures and RiverVest Venture Partners. The new capital means the company can proceed to human tests for its novel type 2 diabetes treatment, which aims to develop a pill to help patients regulate their blood sugar....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders